Using Parallel Streams of Evidence to Inform Guideline Development: The Case of the 2021 American College of Rheumatology Management of Rheumatoid Arthritis Guideline
暂无分享,去创建一个
Lara A. Kahale | L. Fraenkel | E. Akl | E. S. St. Clair | S. Yaacoub | A. Khamis | J. Bathon | B. England | Amy S Turner | Mounir Al-Gibbawi | Amy S. Turner | E. S. St Clair
[1] Lara A. Kahale,et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2021, Arthritis & rheumatology.
[2] N. Bansback,et al. Patient Preferences for Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review , 2019, The Journal of Rheumatology.
[3] P. Tugwell,et al. Including non‐randomized studies on intervention effects , 2019, Cochrane Handbook for Systematic Reviews of Interventions.
[4] Dylan Kneale,et al. Determining the scope of the review and the questions it will address , 2019, Cochrane Handbook for Systematic Reviews of Interventions.
[5] A. Pollock,et al. Stakeholder involvement in systematic reviews: a scoping review , 2018, Systematic Reviews.
[6] Gordon H Guyatt,et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction , 2016, British Medical Journal.
[7] Raveendhara R. Bannuru,et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2016, Arthritis care & research.
[8] Raveendhara R. Bannuru,et al. American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2015 .
[9] P. Bossuyt,et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 3 of 3. The GRADE approach to developing recommendations , 2011, Allergy.
[10] S. Greenfield,et al. Clinical practice guidelines we can trust , 2011 .